Related references
Note: Only part of the references are listed.Different Susceptibility of T and B Cells to Cladribine Depends On Their Levels of Deoxycytidine Kinase Activity Linked to Activation Status
Federico Carlini et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2022)
Human Monocytes Plasticity in Neurodegeneration
Ilenia Savinetti et al.
BIOMEDICINES (2021)
Long-term peripheral immune cell profiling reveals further targets of oral cladribine in MS
Tobias Moser et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers
Olaf Stuve et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis
Martin Diebold et al.
JOURNAL OF AUTOIMMUNITY (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Glatiramer acetate treatment normalized the monocyte activation profile in MS patients to that of healthy controls
Delgertsetseg Chuluundorj et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Both cladribine and alemtuzumab may effect MS via B-cell depletion
David Baker et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis
Roland Martin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System
Anne Waschbisch et al.
JOURNAL OF IMMUNOLOGY (2016)
Cladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear Cells
Melanie Korsen et al.
PLOS ONE (2015)
Expansion and preferential activation of the CD14+CD16+ monocyte subset during multiple sclerosis
Delgertsetseg Chuluundorj et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Cladribine exerts an immunomodulatory effect on human and murine dendritic cells
Stefan H. P. Kraus et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
2-Chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells
V. Singh et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro
Li Li et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study
Giancarlo Comi et al.
JOURNAL OF NEUROLOGY (2013)
Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis
Krystyna Mitosek-Szewczyk et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Adenosine and its receptors as therapeutic targets: An overview
Sakshi Sachdeva et al.
SAUDI PHARMACEUTICAL JOURNAL (2013)
Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors
Kyle Jensen et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2012)
Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity
Bruno Laugel et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors-An Update
Bertil B. Fredholm et al.
PHARMACOLOGICAL REVIEWS (2011)
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
Gavin Giovannoni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Cladribine in the treatment of hairy cell leukemia: initial and subsequent results
Edward Huynh et al.
LEUKEMIA & LYMPHOMA (2009)
A2A receptors in inflammation and injury:: lessons learned from transgenic animals
Gyoergy Hasko et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Steady-state and inflammatory dendritic-cell development
Ken Shortman et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Increased CXCL8 (IL-8) expression in multiple sclerosis
BT Lund et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)
DJ Mahad et al.
SEMINARS IN IMMUNOLOGY (2003)
Interferon-β treatment alters peripheral blood monocytes chemokine production in MS patients
M Comabella et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
The role and regulation of adenosine in the central nervous system
TV Dunwiddie et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Structure and function of adenosine receptors and their genes
BB Fredholm et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2000)